Works matching IS 10837159 AND DT 2018 AND VI 23 AND IP 6
Results: 23
Can We Hang Our Hats on One Percent?
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 642, doi. 10.1634/theoncologist.2018-0153
- By:
- Publication type:
- Article
Canakinumab and Lung Cancer: Intriguing, but Is It Real?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 697, doi. 10.1634/theoncologist.2017-0485
- By:
- Publication type:
- Article
Multidisciplinary Management of Breast Cancer During Pregnancy.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Implementing Keytruda/Pembrolizumab Testing in Clinical Practice.
- Published in:
- 2018
- By:
- Publication type:
- Question & Answer
Looking Back, Looking Forward: The Ethical Framing of Complementary and Alternative Medicine in Oncology Over the Last 20 Years.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 639, doi. 10.1634/theoncologist.2017-0518
- By:
- Publication type:
- Article
Effect of Concomitant pH‐Elevating Medications with Pazopanib on Progression‐Free Survival and Overall Survival in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 686, doi. 10.1634/theoncologist.2017-0578
- By:
- Publication type:
- Article
Complete Remission Following Pembrolizumab in a Woman with Mismatch Repair‐Deficient Endometrial Cancer and a Germline BRCA1 Mutation.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 650, doi. 10.1634/theoncologist.2017-0526
- By:
- Publication type:
- Article
Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 670, doi. 10.1634/theoncologist.2017-0396
- By:
- Publication type:
- Article
Emerging Perspectives on mTOR Inhibitor‐Associated Pneumonitis in Breast Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 660, doi. 10.1634/theoncologist.2017-0343
- By:
- Publication type:
- Article
Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results‐Medicare Analysis.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 704, doi. 10.1634/theoncologist.2017-0487
- By:
- Publication type:
- Article
Fertility Preservation in Leukemia.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 645, doi. 10.1634/theoncologist.2017-0635
- By:
- Publication type:
- Article
A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 658, doi. 10.1634/theoncologist.2017-0325
- By:
- Publication type:
- Article
A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 656, doi. 10.1634/theoncologist.2017-0624
- By:
- Publication type:
- Article
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers Harboring BRAF V600E Mutations.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 740, doi. 10.1634/theoncologist.2017-0642
- By:
- Publication type:
- Article
A Curative‐Intent Trimodality Approach for Isolated Abdominal Nodal Metastases in Metastatic Colorectal Cancer: Update of a Single‐Institutional Experience.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 679, doi. 10.1634/theoncologist.2017-0456
- By:
- Publication type:
- Article
FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 734, doi. 10.1634/theoncologist.2017-0440
- By:
- Publication type:
- Article
Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 654, doi. 10.1634/theoncologist.2017-0690
- By:
- Publication type:
- Article
Serious Illness Conversations: Paving the Road with Metaphors.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 730, doi. 10.1634/theoncologist.2017-0448
- By:
- Publication type:
- Article
Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B‐Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 722, doi. 10.1634/theoncologist.2017-0361
- By:
- Publication type:
- Article
Refugees in Conflict: Creating a Bridge Between Traditional and Conventional Health Belief Models.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 693, doi. 10.1634/theoncologist.2017-0490
- By:
- Publication type:
- Article
Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal Hypertension.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 712, doi. 10.1634/theoncologist.2017-0337
- By:
- Publication type:
- Article
Successful Ovarian Stimulation for Fertility Preservation in a Patient with Chronic Myeloid Leukemia: Switch from Nilotinib to Interferon‐α.
- Published in:
- Oncologist, 2018, v. 23, n. 6, p. 719, doi. 10.1634/theoncologist.2017-0381
- By:
- Publication type:
- Article